Live-cell imaging is a powerful tool for visualization of the spatio-temporal 34 dynamics of living organisms. Although this technique is utilized to visualize 35 nucleocapsid transport in Marburg virus (MARV)-or Ebola virus-infected cells, 36 the experiments require biosafety level-4 (BSL-4) laboratories, which are 37 restricted to trained and authorized individuals. To overcome this limitation, we 38 developed a live-cell imaging system to visualize MARV nucleocapsid-like 39 structures using fluorescence-conjugated viral proteins, which can be conducted 40 outside BSL-4 laboratories. Our experiments revealed that nucleocapsid-like 41 structures have similar transport characteristics to nucleocapsids observed in 42 MARV-infected cells. This system provides a safe platform to evaluate antiviral 43 drugs that inhibit MARV nucleocapsid transport. 44 45 48 negative-sense RNA genome. It causes severe hemorrhagic fever with high 49 fatality rates. MARV epidemics have occasionally been reported in Central Africa, 50 with the largest one, having a 90% fatality rate, being reported in Angola between 51 2004 and 2005 (CDC, 2014). Currently, there are no approved vaccines or 52 antiviral therapeutics available to prevent or treat MARV infection. Therefore, 53 understanding the interplay between viral and host proteins during MARV 54 replication is necessary to establish countermeasures for the diseases. For 55 example, revealing the mechanisms for the assembly and transport of 56 nucleocapsids, which comprise viral genomic RNA, nucleoprotein (NP), viral 57 proteins (VP24, VP30, VP35), and polymerase L, and are responsible for the 58 transcription and replication of the viral genome, might contribute to the 59 development of new therapeutic options.
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the family Filoviridae, and has a roughly 19 kb non-segmented, single-stranded, Plasmids and transfection. 114 Plasmids encoding the MARV structural proteins (NP, VP35, VP24, L, VP40 and 115 GP): pCAGGS-NP, pCAGGS-VP35, pCAGGS-VP24, pCAGGS-L, pCAGGS-116 VP40, and pCAGGS-GP, and a MARV minigenome-expressing plasmid which 117 encodes a Renilla luciferase were used (Wenigenrath et al., 2010, Hoenen et al., 118 2011). The plasmid pCAGGS-VP30-GFP, coding for the green fluorescent 119 protein-VP30 fusion protein, was produced as previously described (Schudt et al., 
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